These results suggest that NFAT1 overexpression impairs the effector functions of Akt2-OE CTLs, highlighting the critical balance between NFAT activity and cytotoxic potential in maintaining effective T-cell responses against HCC. The gene discussed is NFATC2; the disease is hepatocellular carcinoma.